Bayer Reaches Preliminary Settlement Approval in St. Louis

Pharmaceutical giant says this is a major step in finalizing planned settlement.

Published on Mar. 4, 2026

Got story updates? Submit your updates here. ›

Bayer has announced that the Circuit Court of St. Louis has granted preliminary approval for the company's planned settlement related to ongoing litigation. This is described as a 'first major step' in putting the settlement into effect, with the next step being to notify potential class-action members.

Why it matters

The settlement is a significant development in Bayer's efforts to resolve legal issues stemming from its acquisition of Monsanto. The preliminary approval from the St. Louis court indicates progress towards a final resolution of these cases.

The details

Bayer did not provide specifics on the terms of the planned settlement, but stated that the next step is to notify potential class-action members about the settlement. The company said this preliminary approval by the Circuit Court of St. Louis is a crucial first step in finalizing the settlement.

  • The Circuit Court of St. Louis granted preliminary approval on March 4, 2026.

The players

Bayer

A multinational pharmaceutical and life sciences company.

Got photos? Submit your photos here. ›

What’s next

The next step for Bayer is to notify potential class-action members about the settlement.

The takeaway

This preliminary court approval marks progress for Bayer in resolving the legal issues it has faced since acquiring Monsanto. The company is now one step closer to finalizing a settlement that could help put these lawsuits behind it.